Compare AJANTA PHARMA with J.B.Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs J.B.CHEMICALS - Comparison Results

J.B.CHEMICALS 
   Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA J.B.CHEMICALS AJANTA PHARMA/
J.B.CHEMICALS
 
P/E (TTM) x 22.1 16.9 130.9% View Chart
P/BV x 3.8 2.3 163.3% View Chart
Dividend Yield % 0.9 0.5 183.5%  

Financials

 AJANTA PHARMA   J.B.CHEMICALS
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-19
J.B.CHEMICALS
Mar-18
AJANTA PHARMA/
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs1,422363 391.6%   
Low Rs898255 352.0%   
Sales per share (Unadj.) Rs233.5169.1 138.1%  
Earnings per share (Unadj.) Rs44.016.6 264.9%  
Cash flow per share (Unadj.) Rs52.223.4 222.7%  
Dividends per share (Unadj.) Rs9.002.00 450.0%  
Dividend yield (eoy) %0.80.6 119.9%  
Book value per share (Unadj.) Rs255.1172.5 147.9%  
Shares outstanding (eoy) m88.0283.57 105.3%   
Bonus/Rights/Conversions BBBB-  
Price / Sales ratio x5.01.8 271.8%   
Avg P/E ratio x26.418.6 141.7%  
P/CF ratio (eoy) x22.213.2 168.5%  
Price / Book Value ratio x4.51.8 253.8%  
Dividend payout %20.512.0 169.9%   
Avg Mkt Cap Rs m102,08125,827 395.2%   
No. of employees `0006.83.8 180.3%   
Total wages/salary Rs m4,3072,511 171.5%   
Avg. sales/employee Rs Th3,022.63,747.4 80.7%   
Avg. wages/employee Rs Th633.4665.7 95.1%   
Avg. net profit/employee Rs Th569.1367.8 154.7%   
INCOME DATA
Net Sales Rs m20,55414,135 145.4%  
Other income Rs m211366 57.6%   
Total revenues Rs m20,76514,501 143.2%   
Gross profit Rs m5,6642,178 260.0%  
Depreciation Rs m721570 126.5%   
Interest Rs m1235 33.2%   
Profit before tax Rs m5,1431,940 265.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,273552 230.5%   
Profit after tax Rs m3,8701,387 279.0%  
Gross profit margin %27.615.4 178.8%  
Effective tax rate %24.828.5 86.9%   
Net profit margin %18.89.8 191.8%  
BALANCE SHEET DATA
Current assets Rs m11,81210,470 112.8%   
Current liabilities Rs m3,7762,749 137.4%   
Net working cap to sales %39.154.6 71.6%  
Current ratio x3.13.8 82.1%  
Inventory Days Days7755 140.2%  
Debtors Days Days8278 105.1%  
Net fixed assets Rs m14,3985,811 247.8%   
Share capital Rs m175167 105.0%   
"Free" reserves Rs m22,27714,248 156.3%   
Net worth Rs m22,45214,416 155.7%   
Long term debt Rs m70-   
Total assets Rs m26,96217,649 152.8%  
Interest coverage x444.356.6 785.4%   
Debt to equity ratio x00-  
Sales to assets ratio x0.80.8 95.2%   
Return on assets %14.48.1 178.7%  
Return on equity %17.29.6 179.1%  
Return on capital %23.013.7 167.6%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m10,6826,164 173.3%   
Fx outflow Rs m2,1021,334 157.5%   
Net fx Rs m8,5804,829 177.7%   
CASH FLOW
From Operations Rs m3,7481,231 304.6%  
From Investments Rs m-2,228-208 1,070.6%  
From Financial Activity Rs m-1,475-595 247.7%  
Net Cashflow Rs m45427 10.6%  

Share Holding

Indian Promoters % 73.8 55.4 133.2%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 1.6 3.4 45.7%  
FIIs % 7.6 3.9 194.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.0 37.0 45.9%  
Shareholders   20,968 30,437 68.9%  
Pledged promoter(s) holding % 4.4 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   ALKEM LABORATORIES  FRESENIUS KABI ONCO.  TTK HEALTHCARE  ASTRAZENECA PHARMA  DISHMAN PHARMA  

Compare AJANTA PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 70 Points Higher; Telecom and Banking Stocks Advance(Closing)

Indian share markets traded on a positive note throughout the day and ended marginally higher. The BSE Sensex rose over 350 points intraday.

Related Views on News

AJANTA PHARMA Announces Quarterly Results (2QFY20); Net Profit Down 7.2% (Quarterly Result Update)

Nov 8, 2019 | Updated on Nov 8, 2019

For the quarter ended September 2019, AJANTA PHARMA has posted a net profit of Rs 1 bn (down 7.2% YoY). Sales on the other hand came in at Rs 6 bn (up 18.1% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 8.4% (Quarterly Result Update)

Aug 2, 2019 | Updated on Aug 2, 2019

For the quarter ended June 2019, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 8.4% YoY). Sales on the other hand came in at Rs 6 bn (up 19.8% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 24, 2019 | Updated on Jun 24, 2019

Here's an analysis of the annual report of AJANTA PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of AJANTA PHARMA. Also includes updates on the valuation of AJANTA PHARMA.

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

AJANTA PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 5.9% (Quarterly Result Update)

May 3, 2019 | Updated on May 3, 2019

For the quarter ended March 2019, AJANTA PHARMA has posted a net profit of Rs 889 m (down 5.9% YoY). Sales on the other hand came in at Rs 5 bn (down 2.9% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

More Views on News

Most Popular

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

These 10 Days Are Crucial for Getting Rich in the Smallcap Rebound(Profit Hunter)

Nov 5, 2019

How to avoid the most common investing mistake and make the most of the smallcap rebound.

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

What to Buy at Sensex 40,000(The 5 Minute Wrapup)

Nov 4, 2019

Should you invest in high-quality, safe stocks or make some contrarian bets in the smallcap space?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

AJANTA PHARMA SHARE PRICE


Nov 15, 2019 (Close)

TRACK AJANTA PHARMA

  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AJANTA PHARMA 5-YR ANALYSIS

COMPARE AJANTA PHARMA WITH

MARKET STATS